ESC 365 - Inhibiting doxorubicin-induced cardiotoxicity by endothelial protection.

HFA Premium Access

Inhibiting doxorubicin-induced cardiotoxicity by endothelial protection.

Session: Cancer and the heart

Topic: Cancer/Cardiotoxicity

Speaker: Professor K. Alitalo (Helsinki, FI)

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Congress Presentation

Add to my library

About the speaker

Professor Kari Alitalo

Wihuri Research Institute, Helsinki (Finland)

1 presentation

0 follower

3 more presentations in this session

Clinical perspective.

Speaker: Doctor A. Lyon (London, GB)

Metabolic aspects.

Speaker: Doctor H. Taegtmeyer (Houston, US)

Obesity and chemotherapy toxicity.

Speaker: Professor C. Vergely (Dijon, FR)

Access the full session

Cancer and the heart

Speakers: Professor K. Alitalo, Doctor A. Lyon, Doctor H. Taegtmeyer, Professor C. Vergely

About the event

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources